“Global Ophthalmic Devices market set to grow to $60.8bn by 2025” says new Visiongain report

12 March 2020
Pharma

Visiongain has launched a new pharma report Global Ophthalmic Devices Market 2020-2030: Vision Care, Surgical, Diagnostics and Monitoring, OCT Machines, Autorefractor/Keratometer, Fundus Camera, Slit Lamp, OR Microscope, Optical Biometry, Tonometer, Perimeter, Cataract Surgery, Refractive Surgery, Vitro Retinal Surgery, Glaucoma Surgery, Spectacles, Contact Lenses, Daily Disposables.

The medical devices industry is one of the largest and fastest growing markets in the medical and pharmaceutical industries. Rise in geriatric population has led to a rise in ophthalmic conditions such as cataract and diabetic retinopathy. Moreover, rising disposable income, growing awareness of ophthalmic conditions coupled with favourable reimbursement policies of government will further boost the overall growth of ophthalmic surgical devices market.

The lead analyst of the report commented "The global ophthalmic surgical and vision care markets are large, dynamic and growing. As the world’s population grows and ages, the need for quality eye care is expanding and evolving. Advancements in technology have led to the replacement of conventional techniques and devices. There is an increasing prevalence of many eye diseases, especially those linked to chronic diseases such as diabetes. A relatively rich R&D pipeline will improve the diagnostics of ophthalmic diseases and outcomes of surgical procedures.

Current limitations of pharmaceutical treatments, as well of ophthalmic diagnostics and monitoring and surgical devices will continue to drive innovation. Patient compliance and cost effectiveness will be a key factor to consider in future device development."

Leading companies featured in the report include Abbott Medical Optics (AMO), Alcon, Bausch and Lomb (B&L), Carl Zeiss AG Meditec, Haag-Streit Holding AG, Hoya, Johnson & Johnson (J&J), Nidek, STAAR, TopCon, Zeimer Ophthalmic Solutions.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes OTC Drugs & Dietary Supplements Market Report 2020-2030

The increasing rates of patent expiry lead to a counter-strategy of switching companies from Rx to OTC. In the US, according to the Consumer Healthcare Products Association, approximately 106 ingredients and dosage strengths have undergone a change from Rx to OTC to around 700 OTC products on the market.

23 September 2020

Read

Visiongain Publishes Healthcare Cold Chain Logistics Market Report 2020-2030

. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.

16 September 2020

Read

Visiongain Publishes Vaccines Sales Market Report 2020-2030

Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.

14 September 2020

Read

Visiongain Publishes Ophthalmic Ultrasound Systems Market Report 2020-2030

The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.

09 September 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever